Results 181 to 190 of about 28,830 (241)

Análisis cinético de la descomposición térmica del Efavirenz y estudios de compatibilidad con excipientes seleccionados [PDF]

, 2008
Osnir de Sá Viana, Adriano Antunes de Souza Araújo, Rodrigo Almeida Simões, José Lamartine Soares‐Sobrinho, Charlene Regina Santos Matos, Severino Grangeiro Júnior, Cláudio Moreira de Lima, Pedró José Rolim Neto   +7 more
openalex  

CYP2B6 polymorphisms and suicidal behaviour in people living with HIV treated with efavirenz-containing combination antiretroviral therapy: a global case-control study. [PDF]

Front Pharmacol
Arenas-Pinto A, Nordwall J, Carey D, Fletcher CV, Badley AD, Thompson G, Reilly C, Safo SE, Grund B, Lundgren J.   +9 more
europepmc   +1 more source

Synthesis, in vitro anti-HIV-1 reverse transcriptase evaluation, molecular modelling, DFT analysis and acute oral toxicity assessment of benzotriazole derivatives. [PDF]

Sci Rep
Maiti NJ, Ganguly S, Choowongkomon K, Seetaha S, Saehlee S, Aiebchun T, Ghosh R, Khan MA, Debnath B, Nath R, Ashique S, Singh NK, Ansari MY, Tariq M, Niazi P.   +14 more
europepmc   +1 more source

To Switch or not to Switch: are there any Antiretroviral Strategies to Attenuate Weight Gain in People with HIV? [PDF]

Curr HIV/AIDS Rep
Debroy P, Lake JE.
europepmc   +1 more source

Infant HIV transmission despite maternal viral suppression: a case of post-weaning seroconversion. [PDF]

J Antimicrob Chemother
Nakalema S, Namuddu D, Kyohairwe I, Nakatudde I, Malaba T, Myer L, Colbers A, Reynolds H, Read J, Lamorde M, Khoo S, Waitt C.   +11 more
europepmc   +1 more source

R263K-associated dolutegravir resistance on tenofovir, lamivudine and dolutegravir: Implications for earlier genotyping and regimen optimisation. [PDF]

S Afr J Infect Dis
Naidoo S.
europepmc   +1 more source

Efavirenz treatment improves retinal vaso-obliteration and pathological neovascularization in a mouse model of retinopathy of prematurity. [PDF]

Front Med (Lausanne)
Bailey B, Rudd Zhong Manis J, Seth G, Rajpurohit S, Oxenrider A, Martin PM, Jadeja RN, Thounaojam MC.   +7 more
europepmc   +1 more source

Antiretroviral therapy and associated drug interactions with cardiovascular drugs: a critical review. [PDF]

Front Pharmacol
Spanakis M, Alexakis K, Ioannou P.
europepmc   +1 more source

Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVE. [PDF]

Lancet HIV
Kileel EM, Malvestutto CD, Zanni MV, Davies-Smith E, Fichtenbaum CJ, Lake JE, Lo J, Aberg JA, Martinez E, Patel K, Bloomfield GS, Chu SM, Awwad A, Diggs MR, Lu AB, Bares SH, Berrner D, Smieja M, Okeke NL, Kumar P, João E, Currier JS, Lu MT, Fox MP, Brennan AT, Douglas PS, Grinspoon SK, Ribaudo HJ.   +27 more
europepmc   +1 more source

Pharmacokinetics of efavirenz administered in the form of inorganic microparticles in rabbits

, 2018
Evelin dos Santos [UNESP] Martins
openalex   +1 more source